Literature DB >> 11413146

The N-terminal and C-terminal domains of RAP1 are dispensable for chromatin opening and GCN4-mediated HIS4 activation in budding yeast.

L Yu1, N Sabet, A Chambers, R H Morse.   

Abstract

Repressor activator protein 1 (RAP1) assists GCN4-mediated HIS4 activation by overcoming some repressive aspect of chromatin structure to facilitate GCN4 binding. RAP1 also participates in other nuclear processes, and discrete domains of RAP1 have been shown to have specific properties including DNA binding, DNA bending, transcriptional activation, and silencing and telomere functions. To investigate whether specific domains of RAP1 are required to "open" chromatin and help GCN4 to activate the HIS4 gene, we examined the abilities of different truncated RAP1 proteins to perturb positioned nucleosomes via a nucleosomal RAP1 site in a yeast episome in vivo, and we tested HIS4 activation in yeast strains harboring truncated RAP1 mutants. We found that neither the DNA bending domain nor the putative activation domain of RAP1 is required for its ability to perturb the chromatin structure of a plasmid containing a RAP1 site. Similarly, neither the putative activation domain nor the N-terminal DNA-bending domain was required for GCN4-mediated activation of HIS4. We also used a rap1(ts) mutant to show that continuous occupancy of the HIS4 promoter by RAP1 is required for GCN4-mediated gene activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413146     DOI: 10.1074/jbc.M104354200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Collaborative competition mechanism for gene activation in vivo.

Authors:  Joanna A Miller; Jonathan Widom
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

Review 2.  The different (sur)faces of Rap1p.

Authors:  B Piña; J Fernández-Larrea; N García-Reyero; F-Z Idrissi
Journal:  Mol Genet Genomics       Date:  2003-01-25       Impact factor: 3.291

3.  Identification of a transcriptional activation domain in yeast repressor activator protein 1 (Rap1) using an altered DNA-binding specificity variant.

Authors:  Amanda N Johnson; P Anthony Weil
Journal:  J Biol Chem       Date:  2017-02-14       Impact factor: 5.157

4.  Yeast Rap1 contributes to genomic integrity by activating DNA damage repair genes.

Authors:  Raghuvir S Tomar; Suting Zheng; Deborah Brunke-Reese; Holly N Wolcott; Joseph C Reese
Journal:  EMBO J       Date:  2008-05-15       Impact factor: 11.598

5.  Comparison of ABF1 and RAP1 in chromatin opening and transactivator potentiation in the budding yeast Saccharomyces cerevisiae.

Authors:  Arunadevi Yarragudi; Tsuyoshi Miyake; Rong Li; Randall H Morse
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

6.  The orientation of the C-terminal domain of the Saccharomyces cerevisiae Rap1 protein is determined by its binding to DNA.

Authors:  Béatrice Matot; Yann-Vaï Le Bihan; Rachel Lescasse; Javier Pérez; Simona Miron; Gabriel David; Bertrand Castaing; Patrick Weber; Bertrand Raynal; Sophie Zinn-Justin; Sylvaine Gasparini; Marie-Hélène Le Du
Journal:  Nucleic Acids Res       Date:  2011-12-01       Impact factor: 16.971

7.  Extensive role of the general regulatory factors, Abf1 and Rap1, in determining genome-wide chromatin structure in budding yeast.

Authors:  Mythily Ganapathi; Michael J Palumbo; Suraiya A Ansari; Qiye He; Kyle Tsui; Corey Nislow; Randall H Morse
Journal:  Nucleic Acids Res       Date:  2010-11-16       Impact factor: 16.971

8.  Rap1-mediated nucleosome displacement can regulate gene expression in senescent cells without impacting the pace of senescence.

Authors:  Shufei Song; Javier V Perez; William Svitko; M Daniel Ricketts; Elliot Dean; David Schultz; Ronen Marmorstein; F Brad Johnson
Journal:  Aging Cell       Date:  2019-11-19       Impact factor: 9.304

9.  A conserved acidic patch in the Myb domain is required for activation of an endogenous target gene and for chromatin binding.

Authors:  Emily Ray Ko; Dennis Ko; Carolyn Chen; Joseph S Lipsick
Journal:  Mol Cancer       Date:  2008-10-07       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.